期刊文献+

异柠檬酸裂解酶肽类抑制剂筛选及活性检测

Screening and detecting activity of isocitrate lyase peptide inhibitor
原文传递
导出
摘要 [目的]通过噬菌体的肽库筛选并合成具有抑制ICL活性的多肽。[方法]以ICL为基础,利用Discovery Studio 2.1中ligentfit模块,将筛选出多肽与优化后ICL进行分子对接。合成并进行生物活性检测。[结果]通过噬菌体肽库筛选得到6条的七肽成功和ICL对接。合成后的6条七肽质谱检测结果均正确。对6条七肽进行体外生物活性检测,对ICL酶的活性均明显具有抑制的作用。其中3条七肽抑制率超过了70%。[结论]利用虚拟筛选优化了ICL抑制剂的筛选过程,筛选并合成ICL抑制剂,抑制率为75%、64%、66%、77%、78%、67%,为抗结核多肽药物研发提供基础。 [ Objective ] Using the phage peptide library to screen and synthesize peptides for inhibiting ICL activity. [ Methods ] Based on ICL,via the Discovery Studio 2. 1 simulate, peptides were docked with ICL. The peotides were synthesized and their biological activity were detected. [ Results] 6 heptapeptide were gotten by phage peptide library screening and docked with ICL successfully. The biological activity detecting showed that they all could inhibit the activity of ICL significantly. Three of them were over 70%. [ Conclusion] We optimized the screening of ICL inhibitor, synthesized ICL inhibitor according to the screening result, inhibitor rate 75%, 64%, 66%, 77%, 78% ,67%, and provided experiment data for developing new anti -TB drugs.
出处 《生物技术》 CAS CSCD 北大核心 2014年第6期82-86,共5页 Biotechnology
基金 吉林省科技发展计划项目("以异柠檬酸裂解酶为靶点设计合成肽类抑制剂" 编号:2008110)资助
关键词 异柠檬酸裂解酶 多肽 噬菌体肽库 虚拟筛选 isocitrate lyase, polypeptide, phage peptide library, virtual screening
  • 相关文献

参考文献7

  • 1Cole S T, Brosch R, Parkhill J, et al. Deciphering the biology of Myco- bacterium tuberculosis from the complete genome sequence [ J]. Nature, 1998,393:537 -544.
  • 2朱钧萍,申婧,郭中敏,陆家海.抗菌肽分子优化设计研究进展[J].中国抗生素杂志,2013,38(12):881-885. 被引量:1
  • 3Shoichet BK, Kobilka BK. Structure -based drug screening for G - protein- coupled receptors [J]. Trends Pharmacol Sci, 2012,33:268 - 272.
  • 4Chen L,Morrow JK,Tran HT,et al. From laptop to benchtop to bed- side:structure -baseddrug design on protein targets [ J]. Curr Pharm Des, 2012,18 : 1217 - 1239.
  • 5Du J, Cross TA, Zhou HX. Recent progress in structure - based anti - influenza drug design [J ]. Drug Discov Today,2012,17 : 1111 - 1120.
  • 6张小轶,刘斌,何红秋,杨东,王存新.人类免疫缺陷病毒整合酶二酮酸类抑制剂的三维药效团构建[J].物理化学学报,2009,25(5):817-824. 被引量:3
  • 7Lill MA. Efficient incorporation of protein flexibility and dynamics into molecular docking imulations [J]. Biochemistry (Mosc) ,2011,50:6157 - 6169.

二级参考文献35

  • 1白威,田敏卿,马亚平,刘全忠,李琴,蒋晓慧.HIV-1整合酶抑制剂研究进展[J].中国艾滋病性病,2006,12(1):81-84. 被引量:4
  • 2Jing,N.;Xiong,W.;Guan,Y.;Pallasch,L.;Wang,S.Biochemistry,2002,41(17):5397
  • 3Brodin,P.;Pinskaya,M.;Buckle,M.;Parsch,U.;Romanova,E.;Engels,J.;Gottikh,M.;Mouscadet,J.F.Biochemistry,2002,41(5):1529
  • 4Pommier,Y.;Marchand,C.;Neamati,N.Antiviral.Res.,2000,47(3):139
  • 5Dayam,R.;Sanchez,T.;Clement,O.;Shoemaker,R.;Sei,S.;Neamati,N.J.Med.Chem.,2005,48(1):111
  • 6Hazuda,D.J.;Felock,P.;Witmer,M.;Wolfe,A.;Stillmock,K.;Grobler,J.A.;Espeseth,A.;Gabryelski,L.;Schleif,W.;Blau,C.;Miller,M.D.Science,2000,287(5453):646
  • 7Grobler,J.A.;Stillmock,K.;Hu,B.;Witmer,M.;Bourgeois,M.;Melamed,J.;Wai,J.S.;Yong,S.;Vacca,J.;Hazuda,D.J.J.Proc.Natl.Acad.Sci.U.S.A.,2002,99:6661
  • 8Pals,G.C.G.;Zhang,X.C.;Marchand,C.;Neamati,N.;Cowansage,K.;Svarovskaia,E.S.;Pathak,V.K.;Tang,Y.;Nicklaus,M.;Pommier,Y.;Burke,T.R.J.Med.Chem.,2002,45:3184
  • 9Lataillade,M.;Kozal,M.J.AIDS Patient Care STDS,2006,20(7):489
  • 10Billich,A.Curr.Opin.Invest.Drugs,2003,4(2):206

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部